Literature DB >> 22542652

Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder.

R Schennach1, S Meyer, F Seemüller, M Jäger, M Schmauss, G Laux, H Pfeiffer, D Naber, L G Schmidt, W Gaebel, J Klosterkötter, I Heuser, W Maier, M R Lemke, E Rüther, S Klingberg, M Gastpar, H-J Möller, M Riedel.   

Abstract

BACKGROUND: To analyse insight of illness during the course of inpatient treatment, and to identify influencing factors and predictors of insight.
METHODS: Insight into illness was examined in 399 patients using the item G12 of the Positive and Negative Syndrome Scale ("lack of insight and judgement"). Ratings of the PANSS, HAMD, UKU, GAF, SOFAS, SWN-K and Kemp's compliance scale were performed and examined regarding their potential association with insight. The item G12 was kept as an ordinal variable to compare insight between subgroups of patients.
RESULTS: Almost 70% of patients had deficits in their insight into illness at admission. A significant improvement of impairments of insight during the treatment (p<0.0001) was observed. At admission more severe positive and negative symptoms, worse functioning and worse adherence were significantly associated with poorer insight. Less depressive symptoms (p=0.0004), less suicidality (p=0.0218), suffering from multiple illness-episodes (p<0.0001) and worse adherence (p=0.0012) at admission were identified to be significant predictors of poor insight at discharge.
CONCLUSION: The revealed predictors might function as treatment targets in order to improve insight and with it outcome of schizophrenia.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22542652     DOI: 10.1016/j.eurpsy.2012.01.001

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  11 in total

Review 1.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

2.  Metacognitive Deficits Predict Impaired Insight in Schizophrenia Across Symptom Profiles: A Latent Class Analysis.

Authors:  Paul H Lysaker; Emily Gagen; Abigail Wright; Jenifer L Vohs; Marina Kukla; Phillip T Yanos; Ilanit Hasson-Ohayon
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

3.  Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments.

Authors:  Paul H Lysaker; Michelle L Pattison; Bethany L Leonhardt; Scott Phelps; Jenifer L Vohs
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

4.  Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone.

Authors:  Franck Jean Baylé; Arnaud Tessier; Sophie Bouju; David Misdrahi
Journal:  Patient Prefer Adherence       Date:  2015-09-16       Impact factor: 2.711

5.  Accuracy of self-assessment of real-life functioning in schizophrenia.

Authors:  Paola Rocca; Claudio Brasso; Cristiana Montemagni; Silvio Bellino; Alessandro Rossi; Alessandro Bertolino; Dino Gibertoni; Eugenio Aguglia; Mario Amore; Ileana Andriola; Antonello Bellomo; Paola Bucci; Antonino Buzzanca; Bernardo Carpiniello; Alessandro Cuomo; Liliana Dell'Osso; Angela Favaro; Giulia Maria Giordano; Carlo Marchesi; Palmiero Monteleone; Lucio Oldani; Maurizio Pompili; Rita Roncone; Rodolfo Rossi; Alberto Siracusano; Antonio Vita; Patrizia Zeppegno; Silvana Galderisi; Mario Maj
Journal:  NPJ Schizophr       Date:  2021-02-15

6.  Association Between Lack of Insight and Prefrontal Serotonin Transporter Availability in Antipsychotic-Free Patients with Schizophrenia: A High-Resolution PET Study with [11C]DASB.

Authors:  Jeong-Hee Kim; Young-Don Son; Hang-Keun Kim; Jong-Hoon Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2021-10-21       Impact factor: 2.570

7.  Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial.

Authors:  Paul H Lysaker; Peter J Weiden; Xiaowu Sun; Amy K O'Sullivan; Joseph P McEvoy
Journal:  BMC Psychiatry       Date:  2022-08-28       Impact factor: 4.144

8.  Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study.

Authors:  Diego Novick; William Montgomery; Tamas Treuer; Jaume Aguado; Susanne Kraemer; Josep Maria Haro
Journal:  BMC Psychiatry       Date:  2015-08-05       Impact factor: 3.630

9.  A brief intervention to improve exercising in patients with schizophrenia: a controlled pilot study with mental contrasting and implementation intentions (MCII).

Authors:  Pascal Sailer; Frank Wieber; Karl Pröpster; Steffen Stoewer; Daniel Nischk; Franz Volk; Michael Odenwald
Journal:  BMC Psychiatry       Date:  2015-09-03       Impact factor: 3.630

Review 10.  Review of depot aripiprazole for schizophrenia.

Authors:  Farha Bilal Motiwala; Kim Stasia Siscoe; Rif S El-Mallakh
Journal:  Patient Prefer Adherence       Date:  2013-11-13       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.